Guang Yang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Leukemia

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood

Leukemia & lymphoma

Dana Farber Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute Jun 01 2013

United States

Instructor in Medicine :: Medical Oncology

Publications

Hildo C Lantermans, Fangxue Ma, Annemieke Kuil, Sanne van Kesteren, Sevtap Yasinoglu, Guang Yang, Sara J Buhrlage, Jinhua Wang, Nathanael S Gray, Marie José Kersten, Steven P Treon, Steven T Pals, Marcel Spaargaren
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia 38 (7) (2024)
Hildo C Lantermans, Fangxue Ma, Annemieke Kuil, Sanne van Kesteren, Sevtap Yasinoglu, Guang Yang, Sara J Buhrlage, Jinhua Wang, Nathanael S Gray, Marie José Kersten, Steven P Treon, Steven T Pals, Marcel Spaargaren
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia 38 (7) (2024)
Hildo C Lantermans, Fangxue Ma, Annemieke Kuil, Sanne van Kesteren, Sevtap Yasinoglu, Guang Yang, Sara J Buhrlage, Jinhua Wang, Nathanael S Gray, Marie José Kersten, Steven P Treon, Steven T Pals, Marcel Spaargaren
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia 38 (7) (2024)
Hildo C Lantermans, Fangxue Ma, Annemieke Kuil, Sanne van Kesteren, Sevtap Yasinoglu, Guang Yang, Sara J Buhrlage, Jinhua Wang, Nathanael S Gray, Marie José Kersten, Steven P Treon, Steven T Pals, Marcel Spaargaren
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia 38 (7) (2024)
Hildo C Lantermans, Fangxue Ma, Annemieke Kuil, Sanne van Kesteren, Sevtap Yasinoglu, Guang Yang, Sara J Buhrlage, Jinhua Wang, Nathanael S Gray, Marie José Kersten, Steven P Treon, Steven T Pals, Marcel Spaargaren
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia 38 (7) (2024)
Hildo C Lantermans, Fangxue Ma, Annemieke Kuil, Sanne van Kesteren, Sevtap Yasinoglu, Guang Yang, Sara J Buhrlage, Jinhua Wang, Nathanael S Gray, Marie José Kersten, Steven P Treon, Steven T Pals, Marcel Spaargaren
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia (2024)
Jorge J Castillo, Kirsten Meid, Joshua N Gustine, Carly Leventoff, Timothy White, Catherine A Flynn, Shayna R Sarosiek, Maria G Demos, Maria L Guerrera, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Lian Xu, Guang Yang, Andrew R Branagan, Elizabeth O'Donnell, Noopur Raje, Andrew J Yee, Christopher J Patterson, Zachary R Hunter, Steven P Treon
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia. Leukemia (2021)
Steven P Treon, Kirsten Meid, Zachary R Hunter, Catherine A Flynn, Shayna R Sarosiek, Carly R Leventoff, Timothy P White, Yang Cao, Aldo M Roccaro, Antonio Sacco, Maria G Demos, Maria Luisa Guerrera, Amanda Kofides, Xia Liu, Lian Xu, Christopher J Patterson, Manit Munshi, Nicholas Tsakmaklis, Guang Yang, Irene M Ghobrial, Andrew R Branagan, Jorge J Castillo
Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia. Blood 138 (17) (2021)
Jorge J Castillo, John N Allan, Tanya Siddiqi, Ranjana H Advani, Kirsten Meid, Carly Leventoff, Timothy P White, Catherine A Flynn, Shayna R Sarosiek, Andrew R Branagan, Maria G Demos, Maria L Guerrera, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Lian Xu, Guang Yang, Christopher J Patterson, Zachary R Hunter, Matthew S Davids, Richard R Furman, Steven P Treon
Venetoclax in Previously Treated Waldenström Macroglobulinemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Guang Yang, Jinhua Wang, Li Tan, Manit Munshi, Xia Liu, Amanda Kofides, Jiaji G Chen, Nicholas Tsakmaklis, Maria G Demos, Maria Luisa Guerrera, Lian Xu, Zachary R Hunter, Jianwei Che, Christopher J Patterson, Kirsten Meid, Jorge J Castillo, Nikhil C Munshi, Kenneth C Anderson, Michael D Cameron, Sara J Buhrlage, Nathanael S Gray, Steven P Treon
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance. Blood 138 (20) (2021)
Cristina Jiménez, Gloria G Chan, Lian Xu, Nickolas Tsakmaklis, Amanda Kofides, Maria G Demos, Jiaji Chen, Xia Liu, Manit Munshi, Guang Yang, Jorge J Castillo, Adrian Wiestner, Miriam Santero, Steven P Treon, Zachary R Hunter
Genomic evolution of ibrutinib-resistant clones in Waldenström macroglobulinaemia. British journal of haematology 189 (6) (2020)
Stephan J Matissek, Weiguo Han, Mona Karbalivand, Mohamed Sayed, Brendan M Reilly, Shayna Mallat, Shimaa M Ghazal, Manit Munshi, Guang Yang, Steven P Treon, Sarah R Walker, Sherine F Elsawa
Epigenetic targeting of Waldenström macroglobulinemia cells with BET inhibitors synergizes with BCL2 or histone deacetylase inhibition. Epigenomics 13 (2) (2020)
Steven P Treon, Kirsten Meid, Joshua Gustine, Guang Yang, Lian Xu, Xia Liu, Christopher J Patterson, Zachary R Hunter, Andrew R Branagan, Jacob P Laubach, Irene M Ghobrial, Maria Lia Palomba, Ranjana H Advani, Jorge J Castillo
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (6) (2020)
Jorge J Castillo, Gilad Itchaki, Joshua N Gustine, Kirsten Meid, Catherine A Flynn, Maria G Demos, Maria L Guerrera, Cristina Jimenez, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Christopher J Patterson, Lian Xu, Guang Yang, Zachary R Hunter, Steven P Treon
A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia. Leukemia & lymphoma 61 (6) (2020)
Jorge J Castillo, Joshua N Gustine, Kirsten Meid, Catherine A Flynn, Maria G Demos, Maria L Guerrera, Cristina Jimenez, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Christopher J Patterson, Lian Xu, Guang Yang, Zachary R Hunter, Steven P Treon
CXCR4 mutational status does not impact outcomes in patients with Waldenström macroglobulinemia treated with proteasome inhibitors. American journal of hematology 95 (4) (2020)
Joshua N Gustine, Lian Xu, Nicholas Tsakmaklis, Maria G Demos, Amanda Kofides, Jiaji G Chen, Xia Liu, Manit Munshi, Maria Luisa Guerrera, Gloria G Chan, Christopher J Patterson, Andrew Keezer, Kirsten Meid, Toni Dubeau, Guang Yang, Zachary R Hunter, Steven P Treon, Jorge J Castillo
CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia. Blood advances 3 (19) (2020)

Guang Yang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Guang Yang